1. Soft tissue sarcomas in the precision medicine era: new advances in clinical practice and future perspectives
   Giuseppe Badalamenti et al, 2019, La radiologia medica CrossRef
2. Relationship between Fusobacterium nucleatum, inflammatory mediators and microRNAs in colorectal carcinogenesis
   Marcela Alcântara Proença et al, 2018, World Journal of Gastroenterology CrossRef
3. Mutant KRAS promotes liver metastasis of colorectal cancer, in part, by upregulating the MEK-Sp1-DNMT1-miR-137-YB-1-IGF-IR signaling pathway
   Po-Chen Chu et al, 2018, Oncogene CrossRef
4. Upregulation of microRNA‑383 inhibits the proliferation, migration and invasion of colon cancer cells
   Ying Cui et al, 2017, Oncology Letters CrossRef
5. miR-34a Regulates Multidrug Resistance via Positively Modulating OAZ2 Signaling in Colon Cancer Cells
   Yong Li et al, 2018, Journal of Immunology Research CrossRef
6. The comprehensive landscape of miR-34a in cancer research
   Sijing Li et al, 2021, Cancer and Metastasis Reviews CrossRef
7. Relevance of MicroRNAs as Potential Diagnostic and Prognostic Markers in Colorectal Cancer
   Grzegorz Hibner et al, 2018, International Journal of Molecular Sciences CrossRef
8. Dysregulated PDGFR alpha expression and novel somatic mutations in colorectal cancer: association to RAS wild type status and tumor size
   Nadia Ben Jemii et al, 2020, Journal of Translational Medicine CrossRef
9. Antagonism between the RNA-binding protein Musashi1 and miR-137 and its potential impact on neurogenesis and glioblastoma development
   Mitzli X. Velasco et al, 2019, RNA CrossRef
10. Identification of serum miR-34a as a potential biomarker in acute myeloid leukemia
    Yiqun Huang et al, 2018, Cancer Biomarkers CrossRef
11. Long non-coding RNA XIST sponges miR-34a to promotes colon cancer progression via Wnt/β-catenin signaling pathway
    Ningning Sun et al, 2018, Gene CrossRef
12. Non-coding RNAs as potential therapeutic targets for receptor tyrosine kinase signaling in solid tumors: current status and future directions
    Aysan Moeinafshar et al, 2024, Cancer Cell International CrossRef
13. Interplay of Wnt β-catenin pathway and miRNAs in HBV pathogenesis leading to HCC
    Muhammad Adeel Rana et al, 2019, Clinics and Research in Hepatology and Gastroenterology CrossRef
14. MiRNAs in β-Cell Development, Identity, and Disease
    Aida Martinez-Sanchez et al, 2017, Frontiers in Genetics CrossRef
15. Potential roles of microRNAs and ROS in colorectal cancer: diagnostic biomarkers and therapeutic targets
    Jingmei Lin et al, 2017, Oncotarget CrossRef
16. Olaratumab for the treatment of soft-tissue sarcoma
    Alexandra Pender et al, 2017, Future Oncology CrossRef
17. The role of non-coding RNAs in chemotherapy for gastrointestinal cancers
    Fatemeh Dashti et al, 2021, Molecular Therapy - Nucleic Acids CrossRef